What baCta does
baCta develops an AI-powered bioproduction platform that engineers microorganisms to manufacture industrial ingredients for cosmetics, nutrition and animal-feed markets. Its baCtaForge platform combines generative AI, robotics and synthetic biology to design and optimize yeast strains, according to the company. Its first target molecule is astaxanthin, a pigment currently made through petrochemical synthesis or costly algae farming. Founded in Paris in 2024 by Mathieu Nohet and Marie Rouquette, baCta raised a €7 million seed round led by LocalGlobe and Daphni in March 2026.
baCta is a research tool on Falcoscan. AI-powered bioproduction platform that engineers microbes into ingredients. Falcoscan rates baCta with an Opportunity score of 78/100, a Saturation score of 14/100, and a Wrapper-risk score of 15/100. Market signal: rising. baCta is founded in 2024, currently at Seed stage. Pricing: Paid.